To Örebro University

oru.seÖrebro universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Statins and muscle pain
NEMA Research, Inc., Naples, FL, USA.
Department of Medical and Surgical Sciences and Biotechnologies, Unit of Anaesthesia, Intensive Care and Pain Medicine, Sapienza University of Rome, Rome, Italy.
NEMA Research, Inc., Naples, FL, USA; Colucci & Associates, LLC, Newtown, Connecticut, USA.
Centre for Research and Development, Region Gävleborg/Uppsala University, Gävle, Sweden.
Vise andre og tillknytning
2020 (engelsk)Inngår i: Expert Review of Clinical Pharmacology, ISSN 1751-2433, E-ISSN 1751-2441, Vol. 13, nr 3, s. 299-310Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Introduction: Statins remain among the most frequently prescribed drugs and constitute a cornerstone in the prevention of cardiovascular disease. However, muscle symptoms are often reported from patients on statins. Muscle symptoms are frequently reported as adverse events associated with statin therapy.

Areas covered: In the present narrative review, statin-associated muscle pain is discussed. It elucidates potential mechanisms and possible targets for management.

Expert opinion: In general, the evidence in support of muscle pain caused by statins is in some cases equivocal and not particularly strong. Reported symptoms are difficult to quantify. Rarely is it possible to establish a causal link between statins and muscle pain. In randomized controlled trials, statins are well tolerated, and muscle-pain related side-effects is similar to placebo. There are also nocebo effects of statins. Exchange of statin may be beneficial although all statins have been associated with muscle pain. In some patients reduction of dose is worth trying, especially in primary prevention Although the benefits of statins outweigh potential risks in the vast majority of cases, careful clinical judgment may be necessary in certain cases to manage potential side effects on an individual basis.

sted, utgiver, år, opplag, sider
Expert Reviews Ltd. , 2020. Vol. 13, nr 3, s. 299-310
Emneord [en]
Adverse events, cardiovascular disease, statin, muscle pain, myalgia, side effects
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-122186DOI: 10.1080/17512433.2020.1734451ISI: 000517168500001PubMedID: 32089020Scopus ID: 2-s2.0-85080113772OAI: oai:DiVA.org:oru-122186DiVA, id: diva2:1979489
Tilgjengelig fra: 2025-06-30 Laget: 2025-06-30 Sist oppdatert: 2026-01-23bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Magnusson, Peter

Søk i DiVA

Av forfatter/redaktør
Al-Saadi, JonathanMagnusson, Peter
I samme tidsskrift
Expert Review of Clinical Pharmacology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 7 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf